Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Exclusive | The rise of ‘agonorexia’: People are developing brand new eating disorders on GLP-1 agonist drugs

Summary by New York Post
Nearly one in five US adults say they’ve tried a GLP-1 drug to lose weight or manage chronic disease — and while many see results, doctors warn some users are developing dangerous eating disorders.

1 Articles

New York PostNew York Post
Lean Right

Exclusive | The rise of ‘agonorexia’: People are developing brand new eating disorders on GLP-1 agonist drugs

Nearly one in five US adults say they’ve tried a GLP-1 drug to lose weight or manage chronic disease — and while many see results, doctors warn some users are developing dangerous eating disorders.

·New York, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

New York Post broke the news in New York, United States on Friday, January 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

GLP-1 icon

GLP-1

United States icon

United States

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal